Profil
Sheng Wen Yeh is currently Director at Shine-On BioMedical Co., Ltd. since 2022.
Dr. Yeh is also Director at Center Laboratories, Inc. starting in 2025.
Additionally, Dr. Yeh holds the position of General Manager & Associate General Manager at Lumosa Therapeutics Co., Ltd. beginning in 2024.
Dr. Yeh completed a doctorate at the University of Bath, graduate studies at National Taiwan University, and undergraduate studies at National Yang Ming Chiao Tung University.
Aktive Positionen von Sheng Wen Yeh
| Unternehmen | Position | Beginn |
|---|---|---|
| LUMOSA THERAPEUTICS CO., LTD. | Vorstandsvorsitzender | 14.05.2024 |
| SHINE-ON BIOMEDICAL CO.,LTD. | Direktor/Vorstandsmitglied | 01.11.2022 |
| CENTER LABORATORIES, INC. | Direktor/Vorstandsmitglied | 26.06.2025 |
Ausbildung von Sheng Wen Yeh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Taiwan University
National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Center Laboratories, Inc.
Center Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sales allergen extracts and immunotherapy treatment sets | Health Technology |
Lumosa Therapeutics Co., Ltd.
Lumosa Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in new drug development | Health Technology |
National Yang Ming Chiao Tung University
National Yang Ming Chiao Tung University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shine-On BioMedical Co., Ltd.
Shine-On BioMedical Co., Ltd. BiotechnologyHealth Technology Manufactures drugs, antibodies and therapeutics | Health Technology |
















